TORONTO , June 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a cannabis company with core operations in Latin America, announces today...
Khiron Life Sciences Corp - Ordinary Shares
Khiron Life Sciences Corp is a Canada based company involved in cultivating, producing, and distributing THC (tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. Some of the potential uses for medicinal cannabis are disease treatment, pain relief, and disease prevention, including: treatment of epilepsy; slow cell damage in diabetes glaucoma, lower intraocular pressure; treatment of Tourette syndrome among others.
Medical Resources
1d
5d
1m
6m
1y
Max
1d
5d
1m
6m
1y
Max
Khiron Life Sciences Corp - Ordinary Shares News
25 Jun
Khiron President Chris Naprawa to Participate in Grit Capital Virtual Investor Conference
19 Jun
Khiron Completes Acquisition of NettaGrowth International Advancing Multi-Country Operator Strategy
TORONTO , June 19, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a cannabis company with core operations in Latin America, announces that...
17 Jun
Khiron Life Sciences Corp. Joins the Stock Day Podcast to Discuss Expansion in Latin America
PHOENIX, AZ / ACCESSWIRE / June 17, 2019 / The Stock Day Podcast welcomed Khiron Life Sciences Corp. (KHRNF) ("the Company"), a vertically integrated cannabis leader with core operations in Latin America....
14 Jun
Khiron Announces Changes to Leadership Team with Appointment of Wendy Kaufman as CFO
TORONTO, June 14, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), a cannabis company with core operations in Latin America, today announced...
TORONTO , June 7, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a medical cannabis company with core operations in Latin America reports that...
03 Jun
/R E P E A T -- Khiron Announces Completion of New Lab Facilities, With Initial Capacity of 3 Tonnes of Ext
TORONTO, June 2, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin...
02 Jun
Khiron Announces Completion of New Lab Facilities, With Initial Capacity of 3 Tonnes of Extract Per Year
TORONTO , June 2, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America...
Khiron Life Sciences Reports First Quarter Fiscal 2019 Financial Results
30 May
Khiron Life Sciences to Webcast Live on June 4th at VirtualInvestorConferences.com
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com TORONTO , May 30, 2019 /PRNewswire/...
TORONTO , May 29, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core operations in Latin America is pleased to announce today its...
Participation in events
- Cannatech Panama - 2019
- Hotel Central, Panamá, Panama
- Quebec Cannabis Forum
- 2 Rue de la Commune E, Montréal, QC H2Y...
$ 0.02
20.00%
Open:
0.02
High:
0.02
Low:
0.02
Share volume:
185.587 K
Total value:
261.737 K
Market cap:
160.979 M
Symbol:
KHRNF
Contact info
Phone:
705-527-3564
Address:
First Canadian Place, Toronto, ON, Canada
